|
Berg, Kelly A; Evans, Kenda L J; Cropper, Jodie D et al. (2003) Temporal regulation of agonist efficacy at 5-hydroxytryptamine (5-HT)1A and 5-HT 1B receptors. J Pharmacol Exp Ther 304:200-5
|
|
Stout, Brian D; Clarke, William P; Berg, Kelly A (2002) Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence. J Pharmacol Exp Ther 302:957-62
|
|
Evans, K L; Cropper, J D; Berg, K A et al. (2001) Mechanisms of regulation of agonist efficacy at the 5-HT(1A) receptor by phospholipid-derived signaling components. J Pharmacol Exp Ther 297:1025-35
|
|
Berg, K A; Stout, B D; Maayani, S et al. (2001) Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation. J Pharmacol Exp Ther 299:593-602
|
|
Cherstniakova, S A; Bi, D; Fuller, D R et al. (2001) Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes. Drug Metab Dispos 29:1216-20
|
|
Berg, K A; Cropper, J D; Niswender, C M et al. (2001) RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol 134:386-92
|
|
Berg, K A; Stout, B D; Cropper, J D et al. (1999) Novel actions of inverse agonists on 5-HT2C receptor systems. Mol Pharmacol 55:863-72
|
|
Scalzitti, J M; Berg, K A; Kratowicz, S A et al. (1998) Regulation of serotonin2A receptor expression by an antisense oligodeoxynucleotide. J Neurochem 71:1457-63
|
|
Berg, K A; Maayani, S; Goldfarb, J et al. (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 54:94-104
|
|
Berg, K A; Maayani, S; Clarke, W P (1996) 5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism. Mol Pharmacol 50:1017-23
|
Showing the most recent 10 out of 11 publications
